Clinical Trial


20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants


Brief description

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants

Keywords

  •   Pneumococcal Disease

Sponsored By

Pfizer

Unique Study ID

NCT04546425

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

Australian & New Zealand Children's Haematology/Oncology Group
2145, Westmead, New South Wales, Australia
Distance from Current Trial is 0 miles

No Investigator Listed

Bristol-Myers Squibb
2145, Westmead, New South Wales, Australia
Distance from Current Trial is 0 miles

No Investigator Listed

Pfizer
2145, Westmead, New South Wales, Australia
Distance from Current Trial is 0 miles
View All